Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 5
2020 3
2021 6
2022 4
2023 3
2024 5
2025 12
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Donor-derived carbapenem-resistant gram-negative bacterial infections in solid organ transplant recipients: Active surveillance enhances recipient safety.
Mularoni A, Cona A, Campanella M, Barbera F, Medaglia AA, Cervo A, Cuscino N, Di Mento G, Graziano E, El Jalbout JD, Alduino R, Tuzzolino F, Monaco F, Cascio A, Peghin M, Gruttadauria S, Bertani A, Conaldi PG, Mikulska M, Grossi PA. Mularoni A, et al. Among authors: cuscino n. Am J Transplant. 2024 Jun;24(6):1046-1056. doi: 10.1016/j.ajt.2024.02.005. Epub 2024 Feb 9. Am J Transplant. 2024. PMID: 38342183 Free article.
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention.
Baldassarre D, Iacoviello L, Baetta R, Roncaglioni MC, Condorelli G, Remuzzi G, Gensini G, Frati L, Ricciardi W, Conaldi PG, Uccelli A, Blandini F, Bosari S, Scambia G, Fini M, Di Malta A, Amato M, Veglia F, Bonomi A, Klersy C, Colazzo F, Pengo M, Gorini F, Auteri L, Ferrante G, Baviera M, Ambrosio G, Catapano A, Gialluisi A, Malavazos AE, Castelvecchio S, Corsi-Romanelli MM, Cardani R, La Rovere MT, Agnese V, Pane B, Prati D, Spinardi L, Liuzzo G, Arbustini E, Volterrani M, Visconti M, Werba JP, Genovese S, Bilo G, Invitti C, Di Blasio A, Lombardi C, Faini A, Rosa D, Ojeda-Fernández L, Foresta A, De Curtis A, Di Castelnuovo A, Scalvini S, Pierobon A, Gorini A, Valenti L, Luzi L, Racca A, Bandi M, Tremoli E, Menicanti L, Parati G, Pompilio G; CV-PREVITAL Study Group. Baldassarre D, et al. BMJ Open. 2023 Jul 14;13(7):e072040. doi: 10.1136/bmjopen-2023-072040. BMJ Open. 2023. PMID: 37451717 Free PMC article.
DRP1-mediated mitochondrial fragmentation is a druggable vulnerability in multiple myeloma.
Gallo Cantafio ME, Puccio N, Torcasio R, Valentino I, Ganino L, Jin Y, Aktas Samur A, Murfone P, Gallo A, Samur MK, Cuscino N, Giallongo C, Perrotta ID, Ciarrocchi A, Tallarigo F, De Francesco EM, Barbuto D, Jansen-van Vuuren RD, Jedlovčnik L, Wu D, Martino EA, Tibullo D, Di Raimondo F, Gentile M, Neri A, Archer SL, Morelli E, Munshi NC, Viglietto G, Fulciniti M, Amodio N. Gallo Cantafio ME, et al. Among authors: cuscino n. Blood. 2026 Aug 3:blood.2025030349. doi: 10.1182/blood.2025030349. Online ahead of print. Blood. 2026. PMID: 42550764
GMP-compliant, serum-free cultures preserve therapeutic potential of extracellular vesicles from human mesenchymal stromal cells.
Calascibetta F, Martorana A, Lo Pinto M, Carcione C, D'Arpa S, Amico G, Miceli V, Cuscino N, Iannolo G, Volpe L, Scilabra SD, Conaldi PG, Chinnici CM. Calascibetta F, et al. Among authors: cuscino n. Front Cell Dev Biol. 2025 Sep 1;13:1633912. doi: 10.3389/fcell.2025.1633912. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40959666 Free PMC article.
Correction: Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax.
Valentino I, Cantafio MEG, Torcasio R, Murfone P, Ganino L, Gallo A, Cuscino N, Perrotta I, Tallarigo F, Mesuraca M, Gentile M, Viglietto G, Amodio N. Valentino I, et al. Among authors: cuscino n. J Transl Med. 2025 Nov 11;23(1):1258. doi: 10.1186/s12967-025-07052-7. J Transl Med. 2025. PMID: 41219735 Free PMC article. No abstract available.
Immune-Based Biomarkers as Predictors of Mortality in ECMO Therapy for Severe COVID-19 ARDS: Insights from a Retrospective Study.
Busà R, Panarello G, Gallo A, Miceli V, Castelbuono S, Sorrentino MC, Amico G, Carcione C, Russelli G, Cuscino N, Miele M, Timoneri F, Di Bella M, Zito G, Barbera F, Badami E, Corsale AM, Shekarkar Azgomi M, Conaldi PG, Botta C, Bulati M. Busà R, et al. Among authors: cuscino n. Int J Mol Sci. 2025 Dec 30;27(1):390. doi: 10.3390/ijms27010390. Int J Mol Sci. 2025. PMID: 41516267 Free PMC article.
A Multi-Omics Approach Reveals Interleukin 1 Beta Priming as a Key Driver of Immunomodulatory and Regenerative Programs in Adipose-Derived Stem Cells for Osteoarthritis Therapy.
Miceli V, Ligotti ME, Raffo V, Lopa S, Ippolito V, Gallo A, Cuscino N, Scilabra SD, Lo Pinto M, Messina S, D'Arpa S, Moretti M, de Girolamo L, Bulati M, Colombini A. Miceli V, et al. Among authors: cuscino n. Cells. 2026 Jun 9;15(12):1056. doi: 10.3390/cells15121056. Cells. 2026. PMID: 42346083 Free PMC article.
Genomic characterization of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae in bloodstream infections indicates OmpK35 and OmpK36 as pivotal key players in resistance mechanisms.
Vaiana C, Vazzana R, Gagliardo M, Carcione C, Conoscenti E, Blot S, Monaco F, Cardinale F, Di Carlo D, Mularoni A, Agnese V, Conaldi PG, Cuscino N, Gallo A. Vaiana C, et al. Among authors: cuscino n. Front Microbiol. 2026 Jun 15;17:1840520. doi: 10.3389/fmicb.2026.1840520. eCollection 2026. Front Microbiol. 2026. PMID: 42376570 Free PMC article.
45 results